Filing Details
- Accession Number:
- 0001209191-17-064704
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-08 16:23:42
- Reporting Period:
- 2017-12-06
- Accepted Time:
- 2017-12-08 16:23:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1439222 | Agios Pharmaceuticals Inc | AGIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1581950 | Jr. Clayton Lewis Cantley | C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-12-06 | 543 | $57.90 | 80,851 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-06 | 542 | $57.90 | 80,892 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2017-12-06 | 253 | $58.95 | 80,598 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-06 | 254 | $58.95 | 80,638 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2017-12-06 | 204 | $60.01 | 80,394 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-06 | 204 | $60.01 | 80,434 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2017-12-07 | 288 | $59.68 | 80,106 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-07 | 288 | $59.68 | 80,146 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2017-12-07 | 631 | $60.45 | 79,475 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-07 | 631 | $60.45 | 79,515 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 20,803 | Indirect | See footnote |
Common Stock | 20,803 | Indirect | See footnote |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.